IP Library Granted Patent US 10,100,343
Granted Patent B2
US 10,100,343 · App. 15/243,268 · Granted Oct 16, 2018

CRZ1 mutant fungal cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,100,343
App. No.
15/243,268
Granted
Oct 16, 2018
Kind
B2
Abstract

The present invention provides CRZ1 mutant fungal host cells, such as Pichia pastoris . The mutant fungal host cells exhibit temperature-resistance, enhanced fermentation robustness and increased expression of heterologous polypeptides such as immunoglobulins. Methods for producing heterologous polypeptides, such as immunoglobulins, using such mutant fungal host cells are within the scope of the present invention.

Claims (17)

1. An isolated fungal host cell lacking a functional CRZ1 polypeptide with the proviso that the cell comprises a functional ATT1 polypeptide

wherein the endogenous CRZ1 gene encodes an endogenous CRZ1 polypeptide that differs from a wild-type CRZ1 polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 3 in that the endogenous CRZ1 polypeptide comprises the mutation L294→STOP and wherein the fungal host cell is Pichia pastoris comprising a mutated, disrupted, truncated or partially or fully deleted endogenous OCH1.

2. The isolated fungal host cell of claim 1 :

(i) wherein one or more endogenous beta-mannosyltransferase genes of the isolated fungal host cell are mutated, disrupted, truncated or partially or fully deleted;

(ii) wherein the isolated fungal host cell comprises comprising a polynucleotide encoding an alpha-1,2 mannosidase enzyme;

(iii) wherein one or more endogenous phosphomannosyl transferases of the isolated fungal host cell are mutated, disrupted, truncated or partially or fully deleted;

(iv) wherein the isolated fungal host cell comprises comprising a single-subunit oligosaccharyltransferase;

(v) wherein endogenous ALG3 of the isolated fungal host cell is mutated, disrupted, truncated or partially or fully deleted;

(vi) wherein the isolated fungal host cell comprises a polynucleotide encoding an endomannosidase;

(vii) wherein the isolated fungal host cell comprises one or more polynucleotides encoding a bifunctional UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase, an N-acetylneuraminate-9-phosphate synthase, or a CMP-sialic acid synthase;

(viii) comprising a polynucleotide encoding galactosyltransferase;

(ix) comprising a polynucleotide encoding nucleotide sugar transporter;

comprising a polynucleotide encoding sialyltransferase;

(xi) comprising a polynucleotide encoding acetylglucosaminyl transferase; or

(xii) wherein one or more endogenous proteases are mutated, disrupted, truncated or partially or fully deleted.

3. The isolated fungal host cell of claim 1 comprising a heterologous polynucleotide that encodes a heterologous polypeptide.

4. The isolated fungal host cell of claim 2 , wherein the heterologous polypeptide is an immunoglobulin.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2017
From: JIANG, BO; ZHUANG, JUN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 041695/0426 →